Serum matrix metalloproteinase 3 levels are associated with...

PLoS ONE 2018 / 8 Vol. 13; Iss. 8

Serum matrix metalloproteinase 3 levels are associated with an effect of iguratimod as add-on therapy to biological DMARDs in patients with rheumatoid arthritis

Tokai, Nao, Yoshida, Shuzo, Kotani, Takuya, Yoshikawa, Ayaka, Kimura, Yuko, Fujiki, Youhei, Matsumura, Yoko, Takeuchi, Tohru, Makino, Shigeki, Arawaka, Shigeki, Reddy, Sakamuri V.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
13
Language:
english
Journal:
PLOS ONE
DOI:
10.1371/journal.pone.0202601
Date:
August, 2018
File:
PDF, 1.77 MB
english, 2018
Conversion to is in progress
Conversion to is failed